How much weight can you lose on 2.5mg Mounjaro?

The 2.5mg dose: what it's designed to do

A question our prescribers hear most weeks is some version of: "I've been on 2.5mg for a month, why haven't I lost much yet?" The honest answer is that 2.5mg is a tolerability phase. Its job is to let your body adjust to tirzepatide's dual GIP and GLP-1 receptor activity before the dose climbs. The nausea and digestive discomfort that can come with GLP-1 medicines are far more manageable when you start low and titrate gradually, that's the clinical rationale, not a precaution about efficacy.

Most people notice their appetite settling during this phase. Portions feel smaller, snacks feel less compelling. That shift is real and meaningful, but the scale may not move dramatically yet. That's by design. The licensed schedule starts at 2.5mg and steps upward roughly every four weeks under prescriber guidance, through 5mg, 7.5mg and beyond up to 15mg. The doses above 2.5mg are where the trial data becomes striking. You can read about what the full Mounjaro programme typically delivers for a broader picture.

So if you're weighing up whether to start (or you've just started) the 2.5mg figure is not the ceiling. It's the floor.

What the evidence shows at higher doses, and how to think about the numbers

The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults with obesity across the Mounjaro dose range. At 15mg over 72 weeks, average body-weight reduction was around 20–21%. That's a clinical trial figure, it reflects averages across participants who maintained treatment, followed dietary guidance, and stayed in the programme. Individual results vary. A lower maintenance dose will produce a smaller average loss. The 5mg dose page covers what early maintenance results typically look like.

NICE's appraisal of tirzepatide (TA1026) confirmed the clinical case for recommending it for weight management in eligible adults, and that recommendation is built on the full titration trajectory, not the starting dose alone. Thinking about 2.5mg as a standalone treatment misreads the programme. The question worth asking is not "how much will I lose at 2.5mg?" but "what can I expect if I stay on the programme and reach my optimal dose?" That question is worth exploring on our weight-loss expectations page, which also covers factors like baseline weight and metabolic health.

Cost context: what you're actually paying for

Mounjaro is a prescription-only medicine, which means the price you see from any legitimate provider always includes clinical assessment, or it should. Since Eli Lilly raised the UK list price in September 2025, private market rates have ranged roughly £149–£375 per month depending on dose and provider, as widely reported. The 2.5mg starter pen sits at the lower end of that range. But here's the thing: the cheapest listing is rarely the complete picture. Many headline prices exclude the consultation fee, the prescription charge, delivery, and any clinical support between doses. Those costs exist somewhere, either itemised separately or stripped out entirely, which raises its own questions. We have also committed to a Mounjaro price freeze, so you can plan your treatment costs with confidence. For a fuller breakdown of how UK private pricing works, the Mounjaro cost page is worth reading before you commit anywhere.

At nume, we don't compete on price. One transparent figure covers the consultation, prescription, treatment, next-working-day delivery and seven-day aftercare. No subscription, no auto-renewal, every repeat is clinically re-reviewed. You can see current treatment pricing on our treatment page. We lose the headline price comparison on purpose: the service around the medicine is the point.

Why price is the wrong test for a prescription medicine

Mounjaro is a Black Triangle medicine under additional MHRA monitoring. It requires a prescriber who reads your full health picture, not software that ticks boxes. The MHRA has warned publicly about counterfeit weight-loss pens circulating online, some containing insulin rather than tirzepatide. Sellers offering these medicines at prices far below the market rate, or with no clinical assessment involved, are a serious red flag. You can verify any UK online pharmacy on the GPhC register, our registration number is 9012878. Report anything that looks suspicious via the MHRA Yellow Card scheme.

The right question about 2.5mg Mounjaro isn't "how cheap can I get it?", it's "am I starting with a provider whose prescriber will actually manage my titration safely over the months ahead?" That's what determines how much weight you can lose. For a broader look at tirzepatide and what the research says about individual weight-loss potential, our tirzepatide results page has the detail. Ready to find out whether Mounjaro is clinically suitable for you? Speak to our prescribers, the consultation is free and reviewed the same day.